Ticagrelor costs the United States over $750 million annually, yet a BMJ investigation casts new doubts on...
BMJ Group
Over 200 million individuals aged 15–49 likely experienced at least one symptomatic outbreak in 2020, highlighting the...
Researchers emphasize the need for clinical trials to confirm the findings and uncover the reasons behind dark...
In regions with limited vegetation and low rainfall variability, the findings offer a global perspective on how...
An analysis highlights the superiority of triptans such as eletriptan and rizatriptan over newer migraine drugs and...
Researchers say the findings support reconsidering the use of these drugs for most people over 70. A...
